Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VALIDATION OF CLASS I DEVICE SOFTWARE KEY TO DESIGN CONTROL COMPLIANCE, FDA'S TRAUTMAN SAYS; VALIDATION MUST BE DONE EARLY IN DEVELOPMENT PROCESS

This article was originally published in The Gray Sheet

Executive Summary

FDA inspection of Class I device software for compliance with design controls will focus on validation requirements, Kim Trautman, quality systems expert in the agency's Center for Devices and Radiological Health, said Oct. 30 at a Regulatory Affairs Professionals Society meeting in Bethesda, Maryland.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007024

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel